{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:22:43Z","timestamp":1793996563258,"version":"4.8.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,30]]},"abstract":"<jats:p>\n                    Elderly patients with hip fractures are at significantly increased risk of perioperative venous thromboembolism due to multiple comorbidities, functional decline, and prolonged immobilization. Balancing effective thromboprophylaxis with minimizing bleeding risk and improving adherence remains a core challenge in clinical management. Low-molecular-weight heparin (LMWH) is the conventional prophylactic agent, but its injectable administration often results in poor compliance. Rivaroxaban, an oral factor Xa inhibitor, has shown promise; however, clinical evidence in elderly populations remains insufficient. This study aimed to compare the efficacy and safety of rivaroxaban versus LMWH in elderly patients with hip fractures during the perioperative period. A total of 100 elderly hip fracture patients admitted between January 2022 and January 2025 were enrolled and assigned to either the LMWH group (n\u2005=\u200550) or the rivaroxaban group (n\u2005=\u200550). Baseline characteristics, including age, sex, body mass index, blood pressure, heart rate, comorbidities, and surgical methods, showed no significant differences between groups (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&gt;\u2005.05). Perioperative outcomes compared included incidence of venous thrombosis, bleeding complications, mortality, medication adherence, and postoperative recovery. The incidence of deep vein thrombosis was significantly lower in the rivaroxaban group compared with the LMWH group (4.0% vs 10.0%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.03), with a higher thrombosis-free survival rate confirmed by Kaplan\u2013Meier analysis. The overall bleeding event rate was comparable (8.0% vs 6.0%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.75), with no severe bleeding in either group. Thirty-day mortality was low in both groups without significant difference (4.0% vs 2.0%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.69). Rivaroxaban demonstrated slightly better adherence (nonadherence rate 2.0% vs 6.0%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.12). Postoperative recovery was more favorable in the rivaroxaban group, with shorter hospital stay (9.2\u2005\u00b1\u20052.3 vs 10.1\u2005\u00b1\u20052.5 days,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.04) and earlier 1st ambulation (3.8\u2005\u00b1\u20051.2 vs 4.4\u2005\u00b1\u20051.3 days,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.036), while wound healing time did not differ significantly. Rivaroxaban provides superior antithrombotic efficacy compared with LMWH in elderly hip fracture patients during the perioperative period, with comparable safety, better treatment adherence, and enhanced postoperative recovery. These findings suggest rivaroxaban may represent a preferred prophylactic option in this high-risk population, although larger multicenter trials with longer follow-up are warranted to validate its clinical utility.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000047339","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T17:00:46Z","timestamp":1769965246000},"page":"e47339","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Perioperative prevention of venous thrombosis with low-molecular-weight heparin versus rivaroxaban in elderly patients with hip fractures: A retrospective controlled study"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-5729-4129","authenticated-orcid":false,"given":"Xueqin","family":"He","sequence":"first","affiliation":[{"name":"Clinical Pharmacy Department (Pharmacy Section), West China Hospital of Sichuan University, Chengdu City, Sichuan Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Department (Pharmacy Section), West China Hospital of Sichuan University, Chengdu City, Sichuan Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Lou","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Department (Pharmacy Section), West China Hospital of Sichuan University, Chengdu City, Sichuan Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yan","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Department (Pharmacy Section), West China Hospital of Sichuan University, Chengdu City, Sichuan Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Feng","sequence":"additional","affiliation":[{"name":"Clinical Pharmacy Department (Pharmacy Section), West China Hospital of Sichuan University, Chengdu City, Sichuan Province, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260519","doi-asserted-by":"crossref","first-page":"1510344","DOI":"10.3389\/fsurg.2025.1510344","article-title":"Characteristics and treatment strategies of the hip fracture triad.","volume":"12","author":"Li","year":"2025","journal-title":"Front Surg"},{"key":"R2-20260519","doi-asserted-by":"crossref","first-page":"afae194","DOI":"10.1093\/ageing\/afae194","article-title":"Hip fracture has profound psychosocial impacts: a systematic review of qualitative studies.","volume":"53","author":"Taylor","year":"2024","journal-title":"Age Ageing"},{"key":"R3-20260519","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00198-024-07039-y","article-title":"The incidence of subsequent contralateral hip fracture and factors associated with increased risk: the IMPACT Contralateral Fracture Study.","volume":"35","author":"Kay","year":"2024","journal-title":"Osteoporos Int"},{"key":"R4-20260519","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s41999-023-00788-9","article-title":"A standardized clinical pathway for hip fracture patients is associated with reduced mortality: data from the Norwegian Hip Fracture Register.","volume":"14","author":"Garre-Fivelsdal","year":"2023","journal-title":"Eur Geriatr Med"},{"key":"R5-20260519","doi-asserted-by":"crossref","first-page":"e36222","DOI":"10.1016\/j.heliyon.2024.e36222","article-title":"Bibliometric and visualized analysis on hip fracture surgery and venous thromboembolism.","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"R6-20260519","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1186\/s13018-023-04122-8","article-title":"Delayed surgery after hip fracture affects the incidence of venous thromboembolism.","volume":"18","author":"Taoka","year":"2023","journal-title":"J Orthop Surg Res"},{"key":"R7-20260519","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa2205973","article-title":"Aspirin or low-molecular-weight heparin for thromboprophylaxis after a fracture.","volume":"388","author":"O\u2019Toole","year":"2023","journal-title":"N Engl J Med"},{"key":"R8-20260519","first-page":"1381","article-title":"Low molecular weight heparin combined with aspirin to prevent perioperative venous thromboembolism in patients with splenic rupture and lower extremity fracture.","volume":"36","author":"Tang","year":"2022","journal-title":"Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi"},{"key":"R9-20260519","first-page":"1","article-title":"The effect of intermittent pneumatic compression device combined with low-molecular-weight heparin on the prevention of deep vein thrombosis in elderly patients after femoral neck fracture surgery.","volume":"85","author":"Li","year":"2024","journal-title":"Br J Hosp Med (Lond)"},{"key":"R10-20260519","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.injury.2021.11.028","article-title":"Routine use of LMWH prophylaxis is associated with a lower incidence of venous thromboembolic events following an ankle fracture.","volume":"53","author":"Juto","year":"2021","journal-title":"Injury"},{"key":"R11-20260519","doi-asserted-by":"crossref","first-page":"101949","DOI":"10.1016\/j.jcot.2022.101949","article-title":"Venous thromboembolism prophylaxis with low molecular weight heparin versus unfractionated heparin for patients undergoing operative treatment of closed femoral shaft fractures.","volume":"31","author":"Danford","year":"2022","journal-title":"J Clin Orthop Trauma"},{"key":"R12-20260519","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1186\/s12891-024-08213-3","article-title":"Efficacy and safety of aspirin in preventing venous thromboembolism after hip arthroplasty for femoral neck fracture: a noninferiority prospective cohort study.","volume":"25","author":"Zhang","year":"2024","journal-title":"BMC Musculoskelet Disord"},{"key":"R13-20260519","first-page":"e39025","article-title":"Comparison of the efficacy and safety of aspirin and low-molecular-weight heparin in patients with a fracture: a meta-analysis.","volume":"15","author":"Nimerta","year":"2023","journal-title":"Cureus"},{"key":"R14-20260519","doi-asserted-by":"crossref","first-page":"1483611","DOI":"10.3389\/fsurg.2025.1483611","article-title":"Rivaroxaban vs. enoxaparin for preventing venous thromboembolism after hip fracture operations: a retrospective cohort study.","volume":"12","author":"Zheng","year":"2025","journal-title":"Front Surg"},{"key":"R15-20260519","doi-asserted-by":"crossref","first-page":"83","DOI":"10.62347\/JUAO3451","article-title":"Comparative risk of osteoporotic fractures with direct oral anticoagulants versus vitamin K antagonists in atrial fibrillation patients: a systematic review.","volume":"15","author":"Mojahedi","year":"2025","journal-title":"Int J Burns Trauma"},{"key":"R16-20260519","first-page":"e292","article-title":"Expedited surgery does not increase transfusion rates for patients with geriatric hip fracture taking factor Xa inhibitors.","volume":"6","author":"Wang","year":"2023","journal-title":"OTA Int"},{"key":"R17-20260519","first-page":"CD011762","article-title":"Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair.","volume":"1","author":"Salazar","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"key":"R18-20260519","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/ACO.0000000000001356","article-title":"Direct oral anticoagulants in trauma patients.","volume":"37","author":"Sch\u00f6chl","year":"2024","journal-title":"Curr Opin Anaesthesiol"},{"key":"R19-20260519","doi-asserted-by":"crossref","first-page":"e02016","DOI":"10.1213\/XAA.0000000000002016","article-title":"Combined supra-inguinal fascia iliaca compartment block and posterior pericapsular infiltration in patients on rivaroxaban undergoing pertrocanteric fracture surgery: a case series.","volume":"19","author":"Pascarella","year":"2025","journal-title":"A A Pract"},{"key":"R20-20260519","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/BOT.0000000000002974","article-title":"Expedited hip fracture surgery in patients on direct oral anticoagulants does not increase perioperative blood loss.","volume":"39","author":"Wang","year":"2025","journal-title":"J Orthop Trauma"},{"key":"R21-20260519","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.arth.2018.11.029","article-title":"Factor Xa inhibitors and direct thrombin inhibitors versus low-molecular-weight heparin for thromboprophylaxis after total hip or total knee arthroplasty: a systematic review and meta-analysis.","volume":"34","author":"Sun","year":"2019","journal-title":"J Arthroplasty"},{"key":"R22-20260519","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/ans.18305","article-title":"Direct oral anticoagulants for venous thromboembolism prophylaxis in orthopaedic trauma: a clear first choice?","volume":"93","author":"Bhanushali","year":"2023","journal-title":"ANZ J Surg"},{"key":"R23-20260519","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1001\/jamainternmed.2019.6108","article-title":"Clinical effectiveness and safety of aspirin for venous thromboembolism prophylaxis after total hip and knee replacement: a systematic review and meta-analysis of randomized clinical trials.","volume":"180","author":"Matharu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"R24-20260519","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1186\/s13018-025-06092-5","article-title":"NOACs for VTE prevention in patients with lower limb fracture: a systematic review and meta-analysis.","volume":"20","author":"Wu","year":"2025","journal-title":"J Orthop Surg Res"},{"key":"R25-20260519","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.mcna.2024.04.004","article-title":"The patient with hip fracture.","volume":"108","author":"Rudy","year":"2024","journal-title":"Med Clin North Am"},{"key":"R26-20260519","first-page":"313","article-title":"Hospital discharges for hip fracture in older adults, Mexico 2013\u20132022.","volume":"160","author":"Ram\u00edrez-Garc\u00eda","year":"2024","journal-title":"Gac Med Mex"},{"key":"R27-20260519","doi-asserted-by":"crossref","first-page":"103364","DOI":"10.1016\/j.otsr.2022.103364","article-title":"The effectiveness and safety of direct oral anticoagulants compared to conventional pharmacologic thromboprophylaxis in hip fracture patients: a systematic review and meta-analysis of randomized controlled trials.","volume":"109","author":"Abatzis-Papadopoulos","year":"2022","journal-title":"Orthop Traumatol Surg Res"},{"key":"R28-20260519","doi-asserted-by":"crossref","first-page":"160","DOI":"10.36469\/9936","article-title":"Clinical and economic outcomes in low-risk pulmonary embolism patients treated with rivaroxaban versus standard of care.","volume":"6","author":"Peacock","year":"2019","journal-title":"J Health Econ Outcomes Res"},{"key":"R29-20260519","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00590-025-04291-8","article-title":"Comparing residual thrombosis and venous thromboembolism outcomes between patients treated with or without anticoagulant therapy for acute distal lower-limb deep vein thrombosis after total hip arthroplasty.","volume":"35","author":"Tone","year":"2025","journal-title":"Eur J Orthop Surg Traumatol"},{"key":"R30-20260519","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/VIT.VIT_25_24","article-title":"Comparison of the therapeutic effect of different anticoagulation regimens after total hip arthroplasty based on enhanced recovery after surgery: a retrospective study.","volume":"7","author":"Cao","year":"2024","journal-title":"Vasc Investig Ther"},{"key":"R31-20260519","doi-asserted-by":"crossref","first-page":"21514593251345390","DOI":"10.1177\/21514593251345390","article-title":"Does fracture type or surgical technique influence mortality in elderly hip fracture patients?","volume":"16","author":"G\u00fcnaydin","year":"2025","journal-title":"Geriatr Orthop Surg Rehabil"},{"key":"R32-20260519","doi-asserted-by":"crossref","first-page":"111653","DOI":"10.1016\/j.injury.2024.111653","article-title":"Time to surgery and 30-day mortality after hip fracture: an observational study of 29,695 patients reported to the Spanish National Hip Fracture Registry (SNHFR).","volume":"55","author":"Sanz-Reig","year":"2024","journal-title":"Injury"},{"key":"R33-20260519","doi-asserted-by":"crossref","first-page":"afae178.007","DOI":"10.1093\/ageing\/afae178.007","article-title":"Irish hip fracture database frailty index predicts delirium incidence and length of stay in older adults admitted with hip fractures.","volume":"53","author":"Bradley","year":"2024","journal-title":"Age Ageing"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047339","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:04:21Z","timestamp":1779195861000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047339","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"2025-10-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}